Cargando…

Heterogeneity of publicly accessible online critical values for therapeutic drugs

INTRODUCTION: Critical values are reported to clinicians when laboratory values are life threatening and require immediate attention. To date no definitive critical value limit recommendations have been produced regarding therapeutic drug monitoring. Some laboratories choose to publish critical valu...

Descripción completa

Detalles Bibliográficos
Autores principales: McClain, Colt M., Owings, Richard, Bornhorst, Joshua A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263026/
https://www.ncbi.nlm.nih.gov/pubmed/22276244
http://dx.doi.org/10.4103/2153-3539.91131
_version_ 1782221791526125568
author McClain, Colt M.
Owings, Richard
Bornhorst, Joshua A.
author_facet McClain, Colt M.
Owings, Richard
Bornhorst, Joshua A.
author_sort McClain, Colt M.
collection PubMed
description INTRODUCTION: Critical values are reported to clinicians when laboratory values are life threatening and require immediate attention. To date no definitive critical value limit recommendations have been produced regarding therapeutic drug monitoring. Some laboratories choose to publish critical value lists online. These publicly available values may be accessed and potentially utilized by laboratory staff, patient care providers, and patients. MATERIALS AND METHODS: A web-based search of laboratories associated with the Accreditation Council for Graduate Medical Education pathology residency programs was initiated to determine which therapeutic drugs had critical values and to examine the degree of variation in published critical values for these institutions. RESULTS: Of the 107 institutions with university-based pathology training programs, 36 had published critical values online for review. Thirteen therapeutic drugs were investigated and the number of institutions reporting critical value limits for the drug, as well as the median, range, standard deviation, and the coefficient of variation of critical value concentration limits for each drug were determined. A number of the online critical value limits were deemed to be erroneous, most likely due to incorrectly listed units of measurement. CONCLUSIONS: There was a large degree of heterogeneity with regard to the chosen critical value limits for therapeutic drugs. This wide variance in critical values appears to be greater than that observed in interassay proficiency testing. Institutions should reexamine the rationale for their current critical value parameters and ensure that critical value limits and associated units are accurately published online.
format Online
Article
Text
id pubmed-3263026
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-32630262012-01-24 Heterogeneity of publicly accessible online critical values for therapeutic drugs McClain, Colt M. Owings, Richard Bornhorst, Joshua A. J Pathol Inform Original Article INTRODUCTION: Critical values are reported to clinicians when laboratory values are life threatening and require immediate attention. To date no definitive critical value limit recommendations have been produced regarding therapeutic drug monitoring. Some laboratories choose to publish critical value lists online. These publicly available values may be accessed and potentially utilized by laboratory staff, patient care providers, and patients. MATERIALS AND METHODS: A web-based search of laboratories associated with the Accreditation Council for Graduate Medical Education pathology residency programs was initiated to determine which therapeutic drugs had critical values and to examine the degree of variation in published critical values for these institutions. RESULTS: Of the 107 institutions with university-based pathology training programs, 36 had published critical values online for review. Thirteen therapeutic drugs were investigated and the number of institutions reporting critical value limits for the drug, as well as the median, range, standard deviation, and the coefficient of variation of critical value concentration limits for each drug were determined. A number of the online critical value limits were deemed to be erroneous, most likely due to incorrectly listed units of measurement. CONCLUSIONS: There was a large degree of heterogeneity with regard to the chosen critical value limits for therapeutic drugs. This wide variance in critical values appears to be greater than that observed in interassay proficiency testing. Institutions should reexamine the rationale for their current critical value parameters and ensure that critical value limits and associated units are accurately published online. Medknow Publications & Media Pvt Ltd 2011-12-26 /pmc/articles/PMC3263026/ /pubmed/22276244 http://dx.doi.org/10.4103/2153-3539.91131 Text en Copyright: © 2011 McClain CM. http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Original Article
McClain, Colt M.
Owings, Richard
Bornhorst, Joshua A.
Heterogeneity of publicly accessible online critical values for therapeutic drugs
title Heterogeneity of publicly accessible online critical values for therapeutic drugs
title_full Heterogeneity of publicly accessible online critical values for therapeutic drugs
title_fullStr Heterogeneity of publicly accessible online critical values for therapeutic drugs
title_full_unstemmed Heterogeneity of publicly accessible online critical values for therapeutic drugs
title_short Heterogeneity of publicly accessible online critical values for therapeutic drugs
title_sort heterogeneity of publicly accessible online critical values for therapeutic drugs
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263026/
https://www.ncbi.nlm.nih.gov/pubmed/22276244
http://dx.doi.org/10.4103/2153-3539.91131
work_keys_str_mv AT mcclaincoltm heterogeneityofpubliclyaccessibleonlinecriticalvaluesfortherapeuticdrugs
AT owingsrichard heterogeneityofpubliclyaccessibleonlinecriticalvaluesfortherapeuticdrugs
AT bornhorstjoshuaa heterogeneityofpubliclyaccessibleonlinecriticalvaluesfortherapeuticdrugs